Merck Appeals $26M Jury Verdict In First Vioxx Case
Merck & Co. said on Thursday that it is appealing the first jury verdict in the series of trials over the painkiller Vioxx. The plaintiff in the case won a $253...To view the full article, register now.
Already a subscriber? Click here to view full article